Elevance Health Inc
NYSE:ELV
Elevance Health Inc
NYSE:ELV
Price:
544.68 USD
0.56%
Market Closed
Updated:
May 21, 2024
Section:
Relative Value
The Relative Value of one
ELV
stock under the Base Case scenario is
932.21
USD.
Compared to the current market price of 544.68 USD,
Elevance Health Inc
is
Undervalued by 42%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ELV
Relative Value
Base Case
932.21
USD
Undervaluation 42%
Valuation Multiples
Multiples Across Competitors
ELV Competitors Multiples
Elevance Health Inc Competitors
Elevance Health Inc Competitors
All Countries
| Market Cap | P/S | P/E | P/B | ||||
|---|---|---|---|---|---|---|---|
| US |
|
Elevance Health Inc
NYSE:ELV
|
126.7B USD | 0.7 | 20.3 | 3.1 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
481.8B USD | 1.3 | 31.4 | 5.2 | |
| US |
|
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | 18.6 | 3.2 | |
| US |
|
Humana Inc
NYSE:HUM
|
42.8B USD | 0.4 | 21.5 | 2.7 | |
| US |
|
Centene Corp
NYSE:CNC
|
42B USD | 0.3 | 15.4 | 1.6 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
20.2B USD | 0.6 | 18.9 | 4.5 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 6.8 | 122.3 | 3.3 | |
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
33.7B BRL | 1 | -51.4 | 0.7 | |
| BR |
|
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | 45.8 | 4.6 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
2.6B USD | 2.4 | 42.9 | 4.6 | |
| US |
|
Magellan Health Inc
NASDAQ:MGLN
|
2.5B USD | 0.5 | 8.3 | 1.3 |
P/S Multiple
P/E Multiple
P/B Multiple
You don't have any saved screeners yet
